A tailored Care Home Clinical Assessment Tool (CHCAT) for front line clinicians

为一线临床医生量身定制的疗养院临床评估工具 (CHCAT)

• 批准号: 10083496
• 金额: $ 31.87万
• 依托单位: DEM DX LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10083496
• 关键词: tailored; Care; Home; Clinical; Assessment

DemDx will deliver an urgently needed Care Home focused Clinical Assessment Tool (CHCAT).The need is driven by the introduction of the Enhanced Health in Care Homes initiative-aimed at providing a more proactive health service to the elderly and frail care home residents by increasing frontline clinical support to care home nursing staff, community rapid response teams led primarily by Allied Healthcare Professionals (AHPs).Care home nursing staff and communities teams require expanded generalist knowledge across hundreds of conditions, signs, symptoms and "red flags," recognition of patient-specific comorbidities, and awareness of frequently updated gold standard protocols. These clinicians are urgently calling for tools to support them in their expanded roles.Currently both community and care home clinical teams rely heavily on clinical guidance from GP surgeries (with knock on impact on GP workloads and waiting lists) or over-refer patients to A&E, putting further pressure on acute care pathways including ambulance call outs..CHCAT builds upon DemDx's sector-leading clinical reasoning intelligent support platform (CRISP), co-developed via InnovateUK and NIHR-funded engagement in five NHS Trusts. It is the gold standard in support tools for allied health professionals.CHCAT will be a revolutionary cloud-based clinical assessment tool, using AI and data to support community/care home staff in better, safer, quicker clinical assessment and treatment or referral decisions.Innovations include:* AI allowing dynamic consideration of complex patterns and associations across 10,000s of symptoms, comorbidities and "red flags" in validated NICE data.* A data-driven structure enabling AHPs to make sense of complex data associations to make safe, consistent decisions, with patient-centric data weighting enabling prioritisation of most probable conditions, to inform best referral options* Powered by a 12m-patient CPRD dataset.* Outputs are tailored to ageing-specific clinical assessment pathways for the 5+ most common ailments* CHCAT is fully interoperable, seamlessly integrated into patient primary care/acute pathways.

DemDx将提供急需的护理之家重点临床评估工具（CHCAT）。这一需求是由护理之家的增强健康倡议的引入推动的-旨在通过增加对护理之家护理人员的前线临床支持，为老年人和体弱的护理之家居民提供更积极的健康服务，社区快速反应小组主要由专职医疗保健专业人员（AHPs）领导。护理之家护理人员和社区小组需要在数百种条件，体征，症状和“危险信号”，识别患者特异性合并症，以及了解频繁更新的金标准方案。目前，社区和护理之家的临床团队都严重依赖全科医生手术的临床指导（对全科医生的工作量和等待名单产生影响），或者过度将患者转诊到A&E，这给包括救护车呼叫在内的急性护理途径带来了进一步的压力。CHCAT建立在DemDx行业领先的临床推理智能支持平台（CRISP）的基础上，该平台由InnovateUK和NIHR资助的五个NHS信托基金共同开发。CHCAT将是一个革命性的基于云的临床评估工具，使用人工智能和数据支持社区/护理之家工作人员进行更好、更安全、更快的临床评估和治疗或转诊决策。创新包括：* 人工智能允许动态考虑10，000个症状、合并症和经验证的NICE数据中的“红旗”之间的复杂模式和关联。*数据驱动的结构使AHP能够理解复杂的数据关联，以做出安全、一致的决策，以患者为中心的数据加权能够优先考虑最可能的情况，为最佳转诊方案提供信息 * 由1200万患者的CPRD数据集提供支持。*针对5种以上最常见疾病的特定年龄临床评估路径量身定制输出 * CHCAT完全可互操作，无缝集成到患者初级护理/急性路径中。